Streptococcus suis worldwide, human disease is rarely diagnosed in North America. We studied 73 swine-exposed and 67 non-swine-exposed US adults for antibodies to S. suis serotype 2. Serologic data suggest that human infection with S. suis occurs more frequently than currently documented.
The Study
To test the hypothesis that human infections with S. suis occur more commonly than currently recognized, we examined archived serum samples from 73 swine-exposed and 67 non-swine-exposed adults living in Iowa (9) . These persons had all previously completed occupational history questionnaires detailing their pig exposure and use of personal protective gear. Use of materials was approved by the Institutional Review Board at the University of Iowa. Antibodies to serotype 2 S. suis were measured by an ELISA that used whole S. suis cells (serotype 2, strain 30-336-06) as antigen (10).
The ELISA optical density readings for the 73 swineexposed study participants and 67 non-swine-exposed participants were fi rst compared to the positive-control mean option density read per plate per dilution. Optical densities greater or equal to mean positive-control optical density were considered positive. To be conservative, the titer was defi ned as the last positive dilution before the fi rst negative. Again, when a conservative approach was used, the lowest titer among duplicates was considered as the fi nal antibody titer. We used the Fisher exact test to test the null hypothesis that the exposed group does not have higher incidence of antibody titer >10 than the non-swine-exposed group does. We tested a similar hypothesis for specifi c risk groups exposed to swine (such as nursing or fi nishing swine, use of gloves) compared with groups not exposed to swine. Risk factor analyses were performed with exact logistic regression. Seven (9.6%) of 73 swine-exposed study participants were positive, and 1 (1.5%) of the 67 non-swine-exposed participants was positive.
Study participants who work with both fi nishing and nursery swine had 8.8× the odds of having a titer >10 when compared to nonexposed study participants (exact 95% confi dence interval 1.1-406.3). We identifi ed no positive persons in the group that worked solely with nursery swine, a somewhat unexpected fi nding because most S. suis disease occurs in young pigs. However, our study had relatively few persons who worked exclusively with nursery swine (11/73); most participants worked with both nursery and fi nishing swine. Additionally, no farm-level data on prevalence of S. suis where these persons were employed were collected; therefore, whether those persons worked on farms where S. suis had been confi rmed is not known. Other factors such as age, gender, use of tobacco products, and use of gloves when working with animals were not statistically signifi cant (Table) .
Discussion
In this cross-sectional pilot study, we found that more swine-exposed persons had higher titers of antibodies to S. suis than did non-swine-exposed persons. These data suggest that human infection with S. suis is more common in the United States than currently thought.
Two possible reasons stand out regarding the lack of human S. suis disease in the United States. One possibility is underdiagnosis or misdiagnosis, rather than a true ab- sence of the disease (11) . Supporting this hypothesis are reports showing that S. suis has been mistaken for enterococci, Listeria spp., viridans streptococcus, or Streptococcus pneumoniae (7, 8, 11) . Because of this potential misclassifi cation, previous publications have asserted that S. suis should be considered in the differential diagnosis of septicemia, especially when complicated by meningitis in adults with a recent history of contact with pigs or unprocessed pork (12) .
A second possibility is that S. suis strains colonizing swine in the United States may be less virulent than Asian strains and therefore unlikely to cause overt human disease even when transferred between species. This possibility is supported by molecular analyses showing that many US strains belong to sequence type (ST) 25, whereas most virulent serotype 2 isolates have been ST1 (13) . Finally, these hypotheses are not mutually exclusive; both underdiagnosis/misdiagnosis and the circulation of lower-virulence strains may be occurring, resulting in fewer diagnoses of human S. suis infections in North America (11) .
S. suis infection is an important occupational disease in humans in many countries. In research conducted in S. suis-endemic countries, the annual incidence of S. suis meningitis was ≈3 cases/100,000 swine-exposed people: roughly 1,500× higher than the rate in the nonexposed population (14) . Because of this risk, it has been recommended that persons in daily contact with pigs or pig meat should use protective gloves to avoid skin trauma and subsequent risk for exposure to the bacterium. Because no human vaccine against S. suis exists, suitable preventive measures coupled with education and supervision of those who come in contact with live swine or unprocessed pork are important to decrease the transmission of this organism to humans. However, few studies have been conducted to detect subclinical cases of S. suis infection; therefore, the true incidence of infection among the swine-exposed is unknown.
Because our fi ndings only examined 1 serotype of S. suis, our results may not accurately refl ect antibody prevalence. Because we used a whole-cell ELISA, some antibody reactions may be due to cross-reacting antibodies to other serotypes of S. suis or other species of Streptococcus. However, using a slightly different method and population, other investigators found a higher seroprevalence, particularly among farmers and meat inspectors (15) . This difference may stem partly from the fact that we used a conservative criterion for considering a sample positive, which may further underestimate seroprevalence in our group. For example, 4 study participants (3 swine exposed) were classifi ed as having a titer <10 because the fi rst dilution (1:10) was negative in 1 repeat test. However, these participants' serum samples were repeatedly positive in the other 7 dilutions. Acquisition of human positive control serum as a standard to test our assay would enable us to make more defi nitive comparisons.
Finally, because the samples analyzed for this pilot study were not collected to specifi cally assess S. suis infections, more defi nitive future prospective studies seem indicated. One limitation of this serologic study is that it does not enable us to distinguish antibodies generated as a result of true infection versus exposure to S. suis antigens present in manure or dust in the facility, for example. Additionally, because the questionnaire did not include information on pork consumption or handling of raw pork, those factors could not be examined as potential risks. Future studies might include targeted questionnaires, attempts of bacterial isolation, and serial sera collections to examine serologic evidence of infection. Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 12, December 2008 
